Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Rituximab May Slow Beta-Cell Destruction in Patients With Type 1 Diabetes - (DGNews)
    Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial - (BMJ)
    Glucose Intolerance During Pregnancy Associated With Postpartum Cardiovascular Risk - (DGNews)
    TopAbstracts in Diabetes 12/01/2009 - (DGNews)
    Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function - (N Engl J Med)

    News archive

     Recent webcasts/CME - Diabetes
      Clinical Practice In Type 2 Diabetes: After Metformin And Lifestyle, Then What?
      Diabetes and the Heart: Diabetes and Glycemic Control - Endocrine
      Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Diabetes and the Heart: Cardiometabolic Screening and Hospital Care
      Diabetes and the Heart: Diabetes and Glycemic Control - Cardiovascular

      Webcasts/CME archive

       Recent cases - Diabetes
        Transient Anti-GAD Antibody Positivity and Acute Pancreatitis with Pancreas Tail Swelling in a Patient with Susceptible Haplotype for Type 1 Diabetes Mellitus
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Heavy Proteinuria May Speed Progression Of Diabetic Nephropathy

        A DGReview of :"Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy."
        Journal of Diabetes and its Complications

        01/13/2003
        By David Loshak


        Heavy proteinuria may quicken the progression of diabetic nephropathy, say researchers.

        The process may be a result of the increase in the expression of monocyte chemoattractant protein-1 in renal tubuli, say investigators at Akita University School of Medicine, Akita, Japan.

        Monocyte chemoattractant protein-1 is a chemokine which mediates renal interstitial inflammation, tubular atrophy and interstitial fibrosis. It does so by recruiting monocytes and macrophages into renal tubulointerstitium.

        The investigators noted that recent studies had shown that protein overload in renal tubular cells up-regulated monocyte chemoattractant protein-1 gene and its protein expression.

        They then put forward the idea that increased expression of monocyte chemoattractant protein-1 in renal tubuli, probably triggered by increased leakage of plasma protein from glomerular capillary to tubular fluid, might contribute to renal tubular damage and accelerate diabetic nephropathy.

        The investigators examined urinary excretion levels of monocyte chemoattractant protein-1and N-acetylglucosaminidase, a sensitive marker of renal tubular damage, in 72 Japanese Type II diabetic patients. Twenty nine had normoalbuminuria, 25 had microalbuminuria and 18 had macroalbuminuria.

        The median urinary excretion level of monocyte chemoattractant protein-1 in patients with macroalbuminuria was 394.4 ng/g creatinine, significantly higher than the levels in patients with normoalbuminuria (159.6 ng/g creatinine) and microalbuminuria (193.9 ng/g creatinine). Moreover, urinary monocyte chemoattractant protein-1 excretion level was positively correlated with urinary excretion levels of albumin and N-acetylglucosaminidase in all patients.

        The investigators said that these findings suggested that monocyte chemoattractant protein-1 was produced in renal tubular cells and released into urine in proportion to the degree of proteinuria (albuminuria).
        Journal of Diabetes and its Complications 2003;17(1):11-15. "Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send